Interventional Cardiology

Archives for April 2012

Engage with experts and peers on all aspects of cardiac catheterization.
Avatar of Gregg W Stone, MD

Primary PCI Meta-Analysis: Mortality Trumps All (24 Apr 2012)

Gregg W Stone, MD

In a new meta-analysis Dr. Gregg Stone and members of the Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation concluded that reduction in target-vessel revascularization (TVR) associated with drug-eluting stents (DES) in primary PCI provided a powerful reason for continued use of DES in primary PCI. An accompanying editorial by James Brophy focused on several potential DES weaknesses in the study….

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Richard A. Lange, MD, MBA

Should We Pull the Trigger on Platelet Reactivity Testing (and Put It out of Its Misery)? (19 Apr 2012)

Richard A. Lange, MD, MBA and L. David Hillis, MD

“We said it before, and we’ll say it again: an assessment of platelet reactivity by this method doesn’t effectively identify individuals at high risk for a cardiovascular event following PCI.”

Avatar of Richard A. Lange, MD, MBA

Why Make A Stent Out of Cornstarch? (17 Apr 2012)

Richard A. Lange, MD, MBA and L. David Hillis, MD

Biodegradable stents: here to stay… or will they disappear? A newly-released study reports the long-term results of the first-in-man fully biodegradable coronary stent.